MDxHealth (MDXH) Receivables (2020 - 2026)

MDxHealth (MDXH) has 7 years of Receivables data on file, last reported at $14.3 million in Q1 2026.

• Quarterly Receivables fell 8.24% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (down 8.24% YoY) and the FY2025 annual result came in at $14.7 million, up 1.63% from the prior year.
• Receivables eased to $14.3 million in Q1 2026 per MDXH's latest filing, from $14.7 million in the prior quarter.
• The five-year high for Receivables was $18.7 million in Q4 2022, with the low at $3.2 million in Q2 2025.
• Average Receivables over 5 years is $12.0 million, with a median of $13.1 million recorded in 2024.
• Year-over-year, Receivables soared 104.21% in 2022 and slumped 75.9% in 2025.
• MDxHealth's Receivables stood at $18.7 million in 2022, then slumped by 40.56% to $11.1 million in 2023, then rose by 29.81% to $14.4 million in 2024, then gained by 1.63% to $14.7 million in 2025, then dropped by 2.82% to $14.3 million in 2026.
• Business Quant data shows MDXH's Receivables at $14.3 million in Q1 2026, $14.7 million in Q4 2025, and $18.2 million in Q3 2025.